GlaxoSmithKlins (GSK) and Amicus Therapeutics (FOLD) Announces Amigal Collaboration' Amicus to Receive $30M Upfront, $170M in Potential Milestones
Go back to GlaxoSmithKlins (GSK) and Amicus Therapeutics (FOLD) Announces Amigal Collaboration' Amicus to Receive $30M Upfront, $170M in Potential Milestones| Amicus Therapeutics, Inc. (NASDAQ: FOLD) | Delayed: 14.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.49 | 52 Week High | $11.78 | |||
| Open | $14.49 | 52 Week Low | $4.98 | |||
| Day High | $14.49 | P/E | N/A | |||
| Day Low | $14.49 | EPS | $-1.15 | |||
| Volume | 561,059 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 50.10 +0.58 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.52 | 52 Week High | $45.58 | |||
| Open | $49.93 | 52 Week Low | $37.82 | |||
| Day High | $50.37 | P/E | N/A | |||
| Day Low | $49.88 | EPS | $0.00 | |||
| Volume | 1,397,192 | |||||

